05/27/22 11:27 AMOTC : TOMDF Todos Medical Releases Corporate UpdateTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today released a corporate update from CEO Gerald Commissiong on the Company’s CLIA/CAP-certified labRHEA-AIpositive
05/27/22 8:51 AMOTC : TOMDF conferencesclinical trialcovid-19Todos Medical to Present Final Data from the Tollovir Phase 2 Clinical Trial in Hospitalized COVID-19 Patients at the Personalized Medicine World ConferenceTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that majority-owned subsidiary 3CL Pharma will present final data from the phase 2RHEA-AIneutral
05/06/22 11:17 AMOTC : TOMDF Todos Medical Reports Day 14 Update from Ongoing 30-Day Case Study of Paxlovid Rebound PatientTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. reported a Day 14 update. The updateRHEA-AIneutral
05/02/22 10:02 AMOTC : TOMDF Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength Including 5 Day Dosing, 30 Day Dosing and 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor ClaimTodos Medical, Ltd. (OTCQB:RHEA-AIneutral
04/27/22 9:49 AMOTC : TOMDF Todos Medical Initiates IRB-Waived Tollovid Market Research Study and Announces 50% Price Reduction Until May 30th, 2022Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. has received an InstitutionalRHEA-AIpositive
04/25/22 10:51 AMOTC : TOMDF conferencesTodos Medical to Present at the Emerging Growth ConferenceTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical President andRHEA-AIneutral
04/21/22 7:59 AMOTC : TOMDF managementTodos Medical Appoints Philippe Goix as Chief Commercial Officer for Provista Diagnosticsvia NewMediaWire - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced theRHEA-AIpositive
04/20/22 8:01 AMOTC : TOMDF clinical trialcovid-19Todos Medical Reports 2nd Long COVID Case Study and Launches Website for Physicians and Pediatricians to Indicate Interest in Participating in Tollovid Long COVID Clinical StudyTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. is reporting a case study from Dr.RHEA-AIneutral
04/19/22 7:22 AMOTC : TOMDF Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid by LGC GroupTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group ’s InformedRHEA-AIneutral
04/06/22 8:46 AMOTC : TOMDF covid-19Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the LabelTodos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. applauds the Biden Administration’sRHEA-AIneutral